Does severity of pre-existing chronic hypertension affect preeclampsia severity?
Defining the risk profile of women with stage 1 hypertension: a "time to preeclamptic event" analysis
The American College of Obstetricians and Gynecologists (ACOG) recognize that pre-existing hypertension (having high blood pressure before pregnancy) is a well-known risk factor for preeclampsia. In 2017, the American Heart Association (AHA) updated the criteria for what actually diagnoses someone with high blood pressure- lowering the values- so that a blood pressure measurement over 130/80 mmHg (outside of pregnancy) is now considered Stage 1 Hypertension. But ACOG has not yet changed their guidelines for cutoffs during pregnancy, leaving the line at 140/90 even though that would now be considered Stage 2 Hypertension by the AHA.
In this study, researchers asked if the timing during pregnancy for developing a hypertensive disorder of pregnancy is different for women without hypertension vs. stage 1 hypertension vs. stage 2 hypertension. Among the 3,000 women studied, researchers found that women with stage 1 hypertension before they became pregnant had a doubled risk for preeclampsia compared to women entering pregnancy with normal blood pressure. Researchers also found that the group of women with stage 1 hypertension developed a hypertensive disorder of pregnancy (like preeclampsia) about a week earlier in pregnancy compared to women without high blood pressure before pregnancy. These results suggest the new blood pressure guidelines from the AHA for non-pregnant patients should be kept in mind by OB/GYNs when taking care of pregnant patients, as stage 1 hypertension is becoming a well-established risk factor for preeclampsia and may hint at earlier presentation of the syndrome.
LINK: https://pubmed.ncbi.nlm.nih.gov/33878494/
About Research Roundup
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Related Articles
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...
Hypertensive disorders of pregnancy (HDP), including preeclampsia, affect 1 in 6 pregnancies. HDP is a general term for a range of mild to severe outcomes. Until now there has not been a reliabl...
_levels_detect_early_preeclampsia1746032701.png)
Although there is no definitive treatment for preeclampsia, early screening and detection can allow patients to ensure proper management throughout the remainder of the pregnancy. Currently, preeclam...